Cytodyn Inc (CYDY)

[HouseofCards]

It sounds like the opposite of what you said is what it sounds like. You said they failed ALL trials and did not qualify it with Covid trials only. The FDA is also allowing them to move forward with another, larger phase 3 covid trial for critical patients. If you fail, you're done, you don't move forward. All the FDA has said is give us more data that is more compelling because right now you don't have enough. They didn't say "yo this drug sucks, we're stopping your trial." That's a big difference and an important distinction. Take a look at all of the companies that did not move forward with Phase 3 trials in NASH after their Phase 2 trials. That is failure. Now, will the phase 3 work? Who knows but the data from CD12 is compelling so maybe. I don't think anyone would be acquiring this company based on Covid anyway...they'd be acquiring it for either NASH or Cancer and the data in those indications looks promising as well.

Companies acquire companies with debt all the time so it's very possible that would happen. I'm not saying it's going to, I have no idea what's going to happen.